Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Dr M Cucherat, Universite Lyon, Lyon, France; email@example.com
In patients who have had a myocardial infarction (MI), do reductions in resting heart rate (HR) after treatment with β-blockers (BBs) or calcium-channel blockers (CCBs) reduce mortality and morbidity?
Included studies evaluated BBs or CCBs in patients with a history of MI followed for ⩾1 year with <10% attrition. Outcomes were relation between resting HR reduction and all-cause mortality, cardiac death, cardiovascular (CV) death, sudden death, non-fatal MI recurrence, fatal and non-fatal MI, and cardiac events.
Medline and EMBASE (1966 to January 2006), Cochrane Controlled Trials Register (Issue 4, 2005), reference lists, and conference proceedings were searched for randomised, double-blind, placebo controlled trials (RCTs). 25 RCTs (n = 30 904; mean age range 48-81 y based on 14 RCTs) met …
Source of funding: Servier Inc.